8-K
Current Report
Aardvark Therapeutics, Inc. Filed Acc 0001193125-26-120164
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading ck0001774857-20260323.htm…